Dramatic Clinical Response to a Novel Form of Cell Therapy SL-28 in a Patient with Prostate Cancer and Bone Metastasis: A Case Report

20251 citationsJournal Articlegold Open Access

Authors

Victor Tetz

Kristina Kardava

Olzhas Shulenbayev · Almaty Management University

Maria Vecherkovskaya

Alireza Khodadadi‐Jamayran · New York University

Aristotelis Tsirigos · Precision for Medicine (United States)

George Tetz · Tesla Laboratories (United States)

Abstract

SL-28 was efficient and safe approach in a patient with stage IV prostate cancer, supporting its potential in an allogeneic cell therapy for advanced malignancies.

Topics & Keywords

Mesenchymal stem cell research Bone health and treatments Management of metastatic bone disease

Publication Details

Published in: ImmunoTargets and Therapy

Volume Volume 14, pp. 1201-1207

DOI: 10.2147/itt.s547989

Field-Weighted Citation Impact: 1.67

Command Palette

Dramatic Clinical Response to a Novel Form of Cell Therapy SL-28 in a Patient with Prostate Cancer and Bone Metastasis: A Case Report

Authors

Abstract

Topics & Keywords

Publication Details